A thermostable mRNA vaccine against COVID-19

Cited by (670)

Items 101–200 of 670

1. Nanomedomics
   Ganghao Liang, Wanqing Cao, Dongsheng Tang, Hanchen Zhang, Yingjie Yu, Jianxun Ding, Johannes Karges, Haihua Xiao · 2024 · ACS Nano
2. Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
   Bin Zheng, Wenchang Peng, Mingming Guo, Mengqian Huang, Yuxuan Gu, Tao Wang, Guangjian Ni, Dong Ming · 2021 · Chemical Engineering Journal
3. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review
   Tahereh Seifi, Ali Reza Kamali · 2021 · Medicine in Drug Discovery
4. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
   Chen, Gui-Ling, Li, Xiao-Feng, Dai, Xia-Hong, Li, Nan, Cheng, Meng-Li, Huang, Zhen, Shen, Jian, Ge, Yu-Hua, Shen, Zhen-Wei, Deng, Yong-Qiang et al. · 2022 · The Lancet Microbe
5. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
   Nerea Zabaleta, Wenlong Dai, Urja Bhatt, Cécile Hérate, Pauline Maisonnasse, Jessica A. Chichester, Julio C. Sanmiguel, Reynette Estelien, Kristofer T. Michalson, Cheikh Diop et al. · 2021 · Cell Host & Microbe
6. Plant-Derived Extracellular Vesicles as a Delivery Platform for RNA-Based Vaccine: Feasibility Study of an Oral and Intranasal SARS-CoV-2 Vaccine
   Margherita Alba Carlotta Pomatto, Chiara Gai, Federica Negro, Lucia Massari, Maria Chiara Deregibus, Cristina Grange, Francesco Giuseppe De Rosa, Giovanni Camussi · 2023 · Pharmaceutics
7. Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
   Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie · 2020 · Advanced Drug Delivery Reviews
8. Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
   Zoltán Kis · 2022 · Pharmaceutics
9. mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
   Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash D. Khadela, Jinal Ajabiya · 2022 · Vaccines
10. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses
    Jiawu Wan, Zongmei Wang, Lingli Wang, Liqin Wu, Chengguang Zhang, Ming Zhou, Zhen Fang Fu, Ling Zhao · 2023 · mBio
11. Status Report on COVID-19 Vaccines Development
    Arun Kumar, William E. Dowling, Raúl Gómez Román, Amol B. Chaudhari, Céline Gurry, Tung Thanh Le, Stig Tollefson, Carolyn E. Clark, Valentina Bernasconi, Paul A. Kristiansen · 2021 · Current Infectious Disease Reports
12. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
    Jonas B. Sandbrink, Robin J. Shattock · 2020 · Frontiers in Immunology
13. Advanced technologies for the development of infectious disease vaccines
    Akash Gupta, Arnab Rudra, Kaelan Reed, Róbert Langer, Daniel G. Anderson · 2024 · Nature Reviews Drug Discovery
14. Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
    Iman Mohammed Alfagih, Basmah Nasser Aldosari, Bushra T. AlQuadeib, Alanood S. Almurshedi, Mariyam M. Alfagih · 2020 · Pharmaceutics
15. Advances in the design and development of SARS-CoV-2 vaccines
    Xue‐Liang Peng, Ji‐Si‐Yu Cheng, Hai‐Lun Gong, Meng-Di Yuan, Xiaohong Zhao, Zibiao Li, Dai‐Xu Wei · 2021 · Military Medical Research
16. mRNA vaccines: the most recent clinical applications of synthetic mRNA
    Suji Kwon, Minseon Kwon, Seongeun Im, Kyuri Lee, Hyukjin Lee · 2022 · Archives of Pharmacal Research
17. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
    Qingrui Huang, Kai Ji, Siyu Tian, Fengze Wang, Baoying Huang, Zhou Tong, Shuguang Tan, Junfeng Hao, Qihui Wang, Wenjie Tan et al. · 2021 · Nature Communications
18. Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice
    Maho Kawaguchi, Marin Noda, Akari Ono, Mariko Kamiya, Makoto Matsumoto, Masako Tsurumaru, Shusaku Mizukami, Hidefumi Mukai, Shigeru Kawakami · 2022 · Journal of Pharmaceutical Sciences
19. The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA
    Beatriz Dias Barbieri, David J. Peeler, Karnyart Samnuan, Suzanne Day, Kai Hu, Hadijatou Sallah, John S. Tregoning, Paul F. McKay, Robin J. Shattock · 2024 · Journal of Controlled Release
20. Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance
    S. Chaturvedi, Gustavo Vasen, M. Pablo, Xinyue Chen, N. Beutler, Arjun J. Kumar, Elizabeth J. Tanner, S. Illouz, Donna Rahgoshay, John C. Burnett et al. · 2021 · Cell
21. Role of genomics in combating COVID-19 pandemic
    K.A. Saravanan, Manjit Panigrahi, Harshit Kumar, Divya Rajawat, Sonali Sonejita Nayak, Bharat Bhushan, Triveni Dutt · 2022 · Gene
22. A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
    I‐Jung Lee, Cheng‐Pu Sun, Ping‐Yi Wu, Yu-Hua Lan, I-Hsuan Wang, Wen‐Chun Liu, Joyce Pei‐Yi Yuan, Yu-Wei Chang, Sheng-Che Tseng, Szu-I Tsung et al. · 2022 · Journal of Biomedical Science
23. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines
    Zhongyu Li, Xue‐Qing Zhang, William Ho, Fengqiao Li, Mingzhu Gao, Xin Bai, Xiaoyang Xu · 2022 · ACS Nano
24. Simultaneously ultrasensitive and quantitative detection of influenza A virus, SARS-CoV-2, and respiratory syncytial virus via multichannel magnetic SERS-based lateral flow immunoassay
    Zhenzhen Liu, Chongwen Wang, Shuai Zheng · 2022 · Nanomedicine Nanotechnology Biology and Medicine
25. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape
    Matilde Durán‐Lobato, Ana M. López-Estévez, Ana Sara Cordeiro, Tamara G. Dacoba, José Crecente‐Campo, Dolores Torres, Marı́a José Alonso · 2021 · Advanced Drug Delivery Reviews
26. mRNA vaccines: Past, present, future
    Mia Karam, Georges Daoud · 2022 · Asian Journal of Pharmaceutical Sciences
27. The find of COVID-19 vaccine: Challenges and opportunities
    Marwan ElBagoury, Mahmoud M. Tolba, Hebatallah Ahmed Nasser, Abdul Jabbar, Ahmed M. Elagouz, Yahia Aktham, Amy Hutchinson · 2020 · Journal of Infection and Public Health
28. Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
    Shihui Sun, Lei He, Zhongpeng Zhao, Hongjing Gu, Xin De Fang, Tiecheng Wang, Xiaolan Yang, Shaolong Chen, Yong‐Qiang Deng, Jiangfan Li et al. · 2021 · Cellular and Molecular Immunology
29. An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell Memory
    Ole Audun Werner Haabeth, Julian J.K. Lohmeyer, Adrienne Sallets, Timothy R. Blake, Idit Sagiv-Barfi, Debra Katherine Czerwinski, Blaine McCarthy, Abigail E. Powell, Paul A. Wender, Robert M. Waymouth et al. · 2021 · ACS Central Science
30. Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
    Qi Xiang, Linhao Li, Jie Wu, Miao Tian, Yang Fu · 2022 · Microbiological Research
31. Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
    Defeng Li, Qisong Liu, Meifeng Yang, Haoming Xu, Min‐zheng Zhu, Yuan Zhang, Jing Xu, Cheng‐mei Tian, Jun Yao, Lisheng Wang et al. · 2023 · Bioengineering & Translational Medicine
32. Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines
    Wenjun Zhu, Ting Wei, Yuchun Xu, Qiutong Jin, Yu Chao, Jiaqi Lu, Jun Xu, Jiafei Zhu, Xiaoying Winston Yan, Muchao Chen et al. · 2024 · Nature Communications
33. A single dose of VEGF-A circular RNA sustains in situ long-term expression of protein to accelerate diabetic wound healing
    Jinyu Liu, Yanhao Zhang, Chao Liu, Yuhao Jiang, Zihao Wang, Zongke Guo, Xinsong Li · 2024 · Journal of Controlled Release
34. mRNA vaccines: The future of prevention of viral infections?
    Piotr Rzymski, Agnieszka Szuster‐Ciesielska, Tomasz Dzieciątkowski, Willis Gwenzi, Andrzej Fal · 2023 · Journal of Medical Virology
35. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection
    Yun Tan, Feng Liu, Xiaoguang Xu, Yun Ling, Weijin Huang, Zhaoqin Zhu, Mingquan Guo, Yixiao Lin, Ziyu Fu, Dongguo Liang et al. · 2020 · Frontiers of Medicine
36. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
    Zhan Zhang, Qi Shen, Haocai Chang · 2022 · Frontiers in Immunology
37. Ionizable Lipid Nanoparticles for mRNA Delivery
    Xuefeng Tang, Ying Zhang, Xiaojun Han · 2023 · Advanced NanoBiomed Research
38. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice
    Chao Shang, Xinyu Zhuang, He Zhang, Yiquan Li, Yilong Zhu, Jing Lu, Chenchen Ge, Jianan Cong, Tingyu Li, Mingyao Tian et al. · 2021 · Virology Journal
39. Perspectives on RNA Vaccine Candidates for COVID-19
    Pobitra Borah, Pran Kishore Deb, Nizar A. Al‐Shar’i, Lina A. Dahabiyeh, Katharigatta Narayanaswamy Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran et al. · 2021 · Frontiers in Molecular Biosciences
40. Brief review of the mRNA vaccines COVID-19
    Antonio Vitiello, Francesco Ferrara · 2021 · Inflammopharmacology
41. Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
    Sodiq Ayobami Hameed, Stéphane Paul, Giann Kerwin Y. Dellosa, Dolores Jaraquemada, Muhammad Bashir Bello · 2022 · npj Vaccines
42. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2
    Hai Huang, Caili Zhang, Shuping Yang, Wen Xiao, Qian Zheng, Xiangrong Song · 2021 · Journal of Controlled Release
43. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues
    Chao Shang, Xinyu Zhuang, He Zhang, Yiquan Li, Yilong Zhu, Jing Lu, Chenchen Ge, Jianan Cong, Tingyu Li, Nan Li et al. · 2021 · Journal of Virology
44. Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
    Yong‐Qiang Deng, Na-Na Zhang, Yifei Zhang, Xia Zhong, Sue Xu, Hongying Qiu, Tiecheng Wang, Hui John Zhao, Chao Hui ZHOU, Shulong Zu et al. · 2022 · Cell Research
45. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
    Muhammad Umer Ashraf, Yeji Kim, Sunil Kumar, Dongyeob Seo, Maryam Ashraf, Yong‐Soo Bae · 2021 · Vaccines
46. Delivery of mRNA for regulating functions of immune cells
    Jia Yu Shi, Mengwen Huang, Zi-Dong Lu, Xiao‐Jiao Du, Song Shen, Cong‐Fei Xu, Jun Wang · 2022 · Journal of Controlled Release
47. Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates
    Zhao, Hui, Wang, Tie-Cheng, Li, Xiao-Feng, Zhang, Na-Na, Li, Liang, Zhou, Chao, Deng, Yong-Qiang, Cao, Tian-Shu, Yang, Guan, Li, Rui-Ting et al. · 2021 · Signal Transduction and Targeted Therapy
48. Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines
    Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet, Sonsire Fernández-Castillo, Yanet Climent, Fabrizio Chiodo, Laura Rodríguez, Belinda Sánchez Ramírez, Kalet León, Tays Hernández et al. · 2021 · ACS Central Science
49. Lipid‐Polymer Hybrid “Particle‐in‐Particle” Nanostructure Gene Delivery Platform Explored for Lyophilizable DNA and mRNA COVID‐19 Vaccines
    Zhongyu Li, Xue‐Qing Zhang, William Ho, Xin Bai, Dabbu Kumar Jaijyan, Fengqiao Li, Ranjeet Kumar, Afsal Kolloli, Selvakumar Subbian, Hua Zhu et al. · 2022 · Advanced Functional Materials
50. SARS-CoV-2: vaccines in the pandemic era
    Dandan Li, Qihan Li · 2021 · Military Medical Research
51. Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection
    Jinkai Zang, Yuanfei Zhu, Yu Zhou, Chenjian Gu, Yufang Yi, Shuxia Wang, Shiqi Xu, Gaowei Hu, Shujuan Du, Yannan Yin et al. · 2021 · Cell Discovery
52. Current progress in the development of prophylactic and therapeutic vaccines
    Tingting Li, Ciying Qian, Ying Gu, Jun Zhang, Shaowei Li, Ningshao Xia · 2022 · Science China Life Sciences
53. Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
    Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, Amine Kamen · 2023 · Biomolecules
54. Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
    Nana Zhang, Rongrong Zhang, Yifei Zhang, Kai Ji, Xiao-Chuan Xiong, Qianshan Qin, Peng Gao, Xishan Lu, Hangyu Zhou, Haifeng Song et al. · 2022 · Cell Research
55. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
56. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies
    Akbar Hasanzadeh, Masoomeh Alamdaran, Sepideh Ahmadi, Helena Nourizadeh, Mohammad Aref Bagherzadeh, Mirza Ali Mofazzal Jahromi, Perikles D. Simon, Mahdi Karimi, Michael Richard Hamblin · 2021 · Journal of Controlled Release
57. Deep learning models for predicting RNA degradation via dual crowdsourcing
    Hannah K. Wayment-Steele, Wipapat Kladwang, Andrew M. Watkins, Do Soon Kim, Bojan Tunguz, Walter Reade, Maggie Demkin, Jonathan Romano, Roger Wellington-Oguri, John J. Nicol et al. · 2022 · Nature Machine Intelligence
58. Stabilizing RNA Nanovaccines with Transformable Hyaluronan Dynamic Hydrogel for Durable Cancer Immunotherapy
    Fuhao Jia, Wenping Huang, Yue Yin, Yue Jiang, Qingzhen Yang, Haishui Huang, Guangjun Nie, Hai Wang · 2022 · Advanced Functional Materials
59. Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques – an evaluation of particle properties and efficiency
    David C. Jürgens, Leonie Deßloch, Diana Porras-Gonzalez, Joshua Winkeljann, Sebastian Zielinski, Mathias Munschauer, Andreas Hörner, Gerald Burgstaller, Benjamin Winkeljann, Olivia M. Merkel · 2023 · OpenNano
60. Targeting strategies for mRNA delivery
    Randall A. Meyer, Sarah Y. Neshat, Jordan J. Green, José Luís Santos, Anthony D. Tuesca · 2022 · Materials Today Advances
61. Branched hydrophobic tails in lipid nanoparticles enhance mRNA delivery for cancer immunotherapy
    Yunfeng Yan, Xiaomin Liu, Longyu Wang, Chengfan Wu, Qi Shuai, Yanmei Zhang, Shuai Liu · 2023 · Biomaterials
62. Spike Glycoprotein-Mediated Entry of SARS Coronaviruses
    Lin Wang, Ye Xiang · 2020 · Viruses
63. Innate and adaptive immune responses toward nanomedicines
    Iara Maíra de Oliveira Viana, Sabrina Roussel, Joan Defrêne, Eliana Martins Lima, Frédéric Barabé, Nicolas Bertrand · 2021 · Acta Pharmaceutica Sinica B
64. COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
    G. Novelli, M. Biancolella, R. Mehrian-Shai, V. Colona, A. Brito, N. Grubaugh, V. Vasiliou, L. Luzzatto, J. Reichardt · 2021 · Human Genomics
65. mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo
    Qiannan Cao, Huapan Fang, Huayu Tian · 2024 · Biomaterials
66. Rational development of a combined mRNA vaccine against COVID-19 and influenza
    Qing Ye, Mei Wu, Chao Hui ZHOU, Xishan Lu, Baoying Huang, Ning Zhang, Hui John Zhao, Hang Chi, Xiao‐Jing Zhang, Dandan Ling et al. · 2022 · npj Vaccines
67. An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
    Rahul G Ingle, Wei‐Jie Fang · 2023 · Pharmaceutics
68. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
    Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luis Alberto Breda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed et al. · 2021 · Vaccines
69. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
    Sameer Kumar Malladi, Randhir Singh, Suman Pandey, Savitha Gayathri, Kawkab Kanjo, Shahbaz Ahmed, M. S. A. Alam Khan, Parismita Kalita, Nidhi Girish, Aditya Upadhyaya et al. · 2020 · Journal of Biological Chemistry
70. Design Strategies for and Stability of mRNA–Lipid Nanoparticle COVID-19 Vaccines
    Ting Liu, Yang Tian, Aiping Zheng, Chunying Cui · 2022 · Polymers
71. Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
    Lei Xu, Yuan Cao, XU Ya, Rong Li, Xiaoding Xu · 2023 · Macromolecular Bioscience
72. An Update on mRNA-Based Viral Vaccines
    Subbiah Jeeva, Ki‐Hye Kim, Chong Hyun Shin, Bao‐Zhong Wang, Sang‐Moo Kang · 2021 · Vaccines
73. Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
    Thijs Van de Vyver, Stefaan C. De Smedt, Koen Raemdonck · 2021 · Advanced Drug Delivery Reviews
74. Protective neutralizing epitopes in SARS‐CoV‐2
    Hejun Liu, Ian A. Wilson · 2022 · Immunological Reviews
75. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
    Ameneh Jafari, Fahima Danesh Pouya, Zahra Niknam, Meghdad Abdollahpour‐Alitappeh, Mostafa Rezaei–Tavirani, Yousef Rasmi · 2022 · Molecular Biology Reports
76. Thermostable vaccines: an innovative concept in vaccine development
    Ravinder Kumar, Vartika Srivastava, Piyush Baindara, Aijaz Ahmad · 2022 · Expert Review of Vaccines
77. Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
    Samsara W. Upadhya, Jalees Rehman, Asrar B. Malik, Shuibing Chen · 2021 · Physiology
78. Advances in the design and delivery of RNA vaccines for infectious diseases
    Abhijeet Girish Lokras, Thomas Rønnemoes Bobak, Saahil Sandeep Baghel, Federica Sebastiani, Camilla Foged · 2024 · Advanced Drug Delivery Reviews
79. Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021
    Kun Xu, Lianpan Dai, George F. Gao · 2021 · International Immunology
80. Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
    Sanchita Kar, Popy Devnath, Talha Bin Emran, Trina Ekawati Tallei, Saikat Mitra, Kuldeep Dhama · 2022 · Immunity Inflammation and Disease
81. Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
    Md. Anamul Haque, Archana Shrestha, Constantinos Marios Mikelis, George Mattheolabakis · 2024 · International Journal of Pharmaceutics X
82. Advanced Nanomaterials for Preparedness Against (Re‐)Emerging Viral Diseases
    Eunjung Kim, Eun‐Kyung Lim, Geunseon Park, Chaewon Park, Jong‐Woo Lim, Hyo Jin Lee, Woonsung Na, Minjoo Yeom, Jinyoung Kim, Daesub Song et al. · 2021 · Advanced Materials
83. mRNA Vaccines: Why Is the Biology of Retroposition Ignored?
    Tomislav Domazet‐Lošo · 2022 · Genes
84. One‐Step Formation of Targeted Liposomes in a Versatile Microfluidic Mixing Device
    Shan Han, Xin Shun Sun, Xin Liu et al. · 2022 · Small
85. Biomimetic Nanomaterial Strategies for Virus Targeting: Antiviral Therapies and Vaccines
    Joshua A. Jackman, Bo Kyeong Yoon, Lei Ouyang, Nan Wang, Abdul Rahim Ferhan, Jaeyun Kim, Tetsuro Majima, Nam‐Joon Cho · 2020 · Advanced Functional Materials
86. Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
    Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, Amirali Karimi, Mehrzad MohsseniPour, Pegah Mirzapour, Alireza Barzegary, Farzane Behnezhad, Pedram Habibi, Mohammad Amin Salehi et al. · 2021 · Infectious Disorders - Drug Targets
87. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal and integration DNA in mouse and tree shrew models
    Junzhu Yi, Xinlin Lei, Fangteng Guo, Qiubing Chen, Xueyong Chen, Kaitao Zhao, Chengliang Zhu, Xiaoming Cheng, Jiangwei Lin, Hao Yin et al. · 2023 · Antiviral Research
88. Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design
    Xinhui Cai, Jiao Jiao Li, Tao Liu, Oliver Brian, Jinyan Li · 2021 · Briefings in Functional Genomics
89. RNAdegformer: accurate prediction of mRNA degradation at nucleotide resolution with deep learning
    Shujun He, Baizhen Gao, Rushant Sabnis, Qing Sun · 2023 · Briefings in Bioinformatics
90. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection
    Asuka Takanashi, Colin William Pouton, Hareth A. Al-Wassiti · 2023 · Molecular Pharmaceutics
91. Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells
    Alexandra Roesch, Sarah Zölls, Daniela Stadler, Constanze Helbig, Klaus Wuchner, Gideon F. A. Kersten, Andrea Hawe, Wim Jiskoot, Tim Menzen · 2021 · Journal of Pharmaceutical Sciences
92. Dendritic Cell‐Mimicking Nanoparticles Promote mRNA Delivery to Lymphoid Organs
    Yiming Cao, Jinrong Long, Huisheng Sun, Yiqi Miao, Ye Sang, Haitao Lü, Changxiao Yu, Zhen Zhang, Lin Wang, Jing Yang et al. · 2023 · Advanced Science
93. Delivery of m7G methylated Runx2 mRNA by bone-targeted lipid nanoparticle promotes osteoblastic bone formation in senile osteoporosis
    Jinlong Liu, Yuanwei Zhang, Yan Fen Wu, Guangfeng Li, Ning Ji, Ruina Han, Hua Tang, Xinru Liu, Han Liu, Chengji Wang et al. · 2023 · Nano Today
94. CircRNA based multivalent neuraminidase vaccine induces broad protection against influenza viruses in mice
    Xinyu Yue, Cailing Zhong, Rui Cao, Sizhe Liu, Zhiran Qin, Lin Liu, Yanmei Zhai, Wanyu Luo, Yikai Lian, Mengjie Zhang et al. · 2024 · npj Vaccines
95. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2
    Mohammad Ali Derakhshan, Amir Amani, Reza Faridi Majidi · 2021 · ACS Applied Materials & Interfaces
96. A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
    Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, Shang Yu Gong, Romain Gasser, Guillaume Beaudoin-Bussières, Nathalie Brassard, Annemarie Laumaea, Dani Vézina, Jérémie Prévost et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
97. Emerging Phospholipid Nanobiomaterials for Biomedical Applications to Lab-on-a-Chip, Drug Delivery, and Cellular Engineering
    Maedeh Rahimnejad, Navid Rabiee, Sepideh Ahmadi, Sepideh Jahangiri, S. Mohammad Sajadi, Omid Akhavan, Mohammad Reza Saeb, Woosung Kwon, Mungu Kim, Sei Kwang Hahn · 2021 · ACS Applied Bio Materials
98. Design and lyophilization of mRNA-encapsulating lipid nanoparticles
    Ting Wang, Tao Yu, Wanqi Li, Qian Liu, Tzu‐Cheng Sung, Akon Higuchi · 2024 · International Journal of Pharmaceutics
99. Nanoparticle approaches against SARS-CoV-2 infection
    Yaou Duan, Shuyan Wang, Qiangzhe Zhang, Weiwei Gao, Liangfang Zhang · 2021 · Current Opinion in Solid State and Materials Science
100. The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
     Nitika, Jiao Wei, Ai‐Min Hui · 2021 · Infection and Drug Resistance